216 related articles for article (PubMed ID: 30568241)
1. Moving towards a cure in genetics: what is needed to bring somatic gene therapy to the clinic?
Cornel MC; Howard HC; Lim D; Bonham VL; Wartiovaara K
Eur J Hum Genet; 2019 Mar; 27(3):484-487. PubMed ID: 30568241
[TBL] [Abstract][Full Text] [Related]
2. Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
Baylis F
Clin Chem; 2018 Mar; 64(3):489-491. PubMed ID: 29490999
[No Abstract] [Full Text] [Related]
3. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
Zhang X; Wang L; Liu M; Li D
Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
[TBL] [Abstract][Full Text] [Related]
5. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
Castillo A
Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
[No Abstract] [Full Text] [Related]
6. [The CRISPR-Cas system: beyond genome editing].
Croteau FR; Rousseau GM; Moineau S
Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
[TBL] [Abstract][Full Text] [Related]
7. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle CF; MacLaren RE
Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
9. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
Hohmann S
Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
[No Abstract] [Full Text] [Related]
10. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.
Chadwick AC; Musunuru K
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):12-18. PubMed ID: 28838920
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
12. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
Kuruvilla J; Sasmita AO; Ling APK
Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
[TBL] [Abstract][Full Text] [Related]
14. A new era of gene editing for the treatment of human diseases.
Kc M; Steer CJ
Swiss Med Wkly; 2019 Jan; 149():w20021. PubMed ID: 30685869
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
Memi F; Ntokou A; Papangeli I
Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
[TBL] [Abstract][Full Text] [Related]
16. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
17. New Gene-Editing Tool Slowly Advances Into the Clinic.
Jenks S
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117363
[No Abstract] [Full Text] [Related]
18. The Human Genome Editing Race: Loosening Regulatory Standards for Commercial Advantage?
Cathomen T; Schüle S; Schüßler-Lenz M; Abou-El-Enein M
Trends Biotechnol; 2019 Feb; 37(2):120-123. PubMed ID: 30017092
[TBL] [Abstract][Full Text] [Related]
19. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
